Xenikos secures investment of 30 million dollars
Xenikos B.V. is a clinical-stage biopharmaceutical company, developing innovative new immunotherapies, based on conjugated antibodies, designed to improve patient health and…
A look into the future: developing the CITC
The chip is more and more integrated in a combination of product and package, improving the functions and functionalities of…